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metric show a somewhat larger influence of the calculation 
algorithm used compared to the edge area metric. 
 
Conclusion: Different dose calculation algorithms can 
influence on the correlation between aperture-based 
complexity metric scores and complexity of the treatment 
field. The impact is different for different metrics. 
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Purpose or Objective: To evaluate the feasibility and the 
safety of delivering intraoperative radiotherapy (ELIOT) to 
the tumor bed in breast cancer patients withcardiac 
implantable electronical devices as part of breast 
conservative treatment. Cardiac devices, as pacemakers or 
defibrillators, can suffer from malfunctions as a result of 
exposure to ionizing radiation. Scattered radiation can be 
harmful as direct radiation as well. Measurements of 
absorbed dose during ELIOT in the subclavicular region 
supposed to house cardiac implantable electronical devices 
were carried out in healthy patients without heart disease. 
The aim of the study is to verify that the intraoperative dose 
does not exceed the recommended maximum dose of 2 Gy. 
 
Material and Methods: The present analysis was performed 
on 18 out of 25 patients considered for the study. After 
signing the informed consent, all patients underwent breast 
conserving surgery. After tumor removal and before 
delivering ELIOT to the tumor bed, two catheters, each of 
them containing 8 thermoluminescent dosimeters (TLDs), 
were placed. The first catheter, the internal one, was 
attached to the thoracic shielding (an aluminum–lead disk of 
7-8 cm in diameter) and became an integral part of it. The 
shielding was located beneath the reconstructed breast 
parenchyma of the tumor bed, to minimize the dose to 
underlying tissues and its tip was positioned in the 
subclavicular region, where cardiac devices are supposed to 
be. The second catheter, the external one, was placed on the 
skin, parallel to the first one, next to the applicator (4-5 cm 
of diameter, flat or 15° beveled). The TLD reading showed 
the absorbed dose due to the scattered dose correlated to 
the distance from the applicator. 
 
Results: Given a prescribed dose of 21 Gy at 90% isodose, the 
external TLDs on the skin read a mean dose of 0.32 Gy 
(range, 0.10 – 0.55 Gy), measured starting 1.5 cm from the 
applicator wall up to 10.5 cm. By evaluating the doses 
measured by TLDs in the internal catheter, the minimum 
distance considered safe for cardiac devices was found to be 
2.5 cm from the applicator wall. In fact, at that distance, the 
cumulative scatter radiation dose was lower than 2 Gy. 
Comparing the data from the two catheters, higher doses 
were measured in the internal catheter compared to the 
external one. Therefore, the main source of scattered dose 
was the patient herself rather than the mobile accelerator. 
 
Conclusion: Final results are not available yet, as the study is 
ongoing. However, on the basis of analyzed data, ELIOT 
seems to be safe for patients using cardiac devices as long as 
the minimum distance of 2.5 cm is kept between the cardiac 
device edge and the applicator wall. No correlation with 
tumor site and electron energy was observed. When clinically 
indicated, ELIOT might be a valid alternative to external 
irradiation, which is conditioned by the low threshold dose 
for cardiac devices, as recommended by current guidelines. 
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Purpose or Objective: The in-air output ratio (Sc), describes 
how the photon fluence per monitor unit varies with beam 
collimator settings. In this study, the contribution from 
different accelerator head components to the total Sc was 
investigated for fields generated with and without a 
flattening filter in the beam line. 
 
Material and Methods: Using the EGSnrc-package, a Monte 
Carlo model of the accelerator head of an Elekta Synergy 
linac has been built and verified with measured lateral and 
depth-dose profiles. Four different energy/filter 
combinations were simulated, one conventional 6 MV beam 
with a flattening filter (FF), two flattening filter-free (FFF) 
beams where the flattening filter was replaced by a 2 mm 
thick iron plate and the incident electron energy was kept 
the same as for the FF beam or increased to produce a 
similar depth-dose curve as the FF beam, and one untuned 
beam without any filter in the beam line. Sc was calculated 
as the ratio of primary collision water kerma (Kp) for any 
collimator setting to a reference collimator setting (10×10 
cm²) for the same number of monitor units as defined in Zhu 
et al. (Med Phys 36 5261-91, 2009). Kp was derived from a 
photon spectra scored in air in a circular region with a radius 
of 0.5 cm centred on the central axis 100 cm from the target 
for collimator settings ranging from 3×3 cm² to 40×40 cm². 
The contributions from different parts of the accelerator 
were evaluated using the LATCH variable. The calculated Sc 
was compared to measurements performed with a farmer ion 
chamber with a 2.5 mm brass build-up cap. 
 
Results: Calculated Sc were within 0.4 % of measured values 
for both FF and the energy matched FFF beam. Unscattered 
photons, i.e. photons only interacting in the target, were, as 
expected, found to be invariant relative to the reference 
field and accounted for 98 % and 92 % of the total Sc for the 
conventional FF beam, for the 3×3 cm² and 40×40 cm² fields, 
respectively. For the FFF beams this proportion was 
increased to 99 % and 96 % for the untuned beam and to 99 % 
and 97 % for both the tuned FFF and the beam without metal 
plate (Fig 1). For the FF beam, photons having interacted in 
the flattening filter are the major contributors to the 
variation in Sc for fields larger than 10×10 cm², while for 
smaller fields the contribution from photons interacting in 
the primary collimator have an equal or slightly larger 
impact. However, for the FFF beams, photons interacting in 
the primary collimator are the largest contributors to Sc for 
all field sizes and the difference in contribution from the 
metal plate (if any) and secondary collimators are within the 
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Conclusion: In-air output ratios were successfully calculated 
as the ratio of Kp for beams with and without a flattening 
filter. For FF beams the flattening filter and primary 
collimator was the largest contributors, while for beams with 
2 mm Fe or no filter in the beams line the primary collimator 
accounts major part of the variation of Sc. 
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Purpose or Objective: We report on our initial experience 
with the commissioning for fixed-field IMRT of the dose 
reconstruction algorithm on a phantom with measurements 
from a helical diode detector array (ArcCheck (AC) from Sun 
Nuclear (SNC)). 
 
Material and Methods: We designed a set of tests to check 
on the performance of the dose reconstruction software, 
3DVH, which reconstructs the dose inside the AC device from 
the entrance/exit diode measurements. Dose was measured 
with and without a small volume ionization chamber (0.125 
cc semi-flex by PTW). Dose in the position of the ionization 
chamber was estimated with the help of 3DVH. TPS 
calculated dose and reconstructed dose were compared to 
the ionization chamber dose.  
Linearity was assessed by irradiating 10x10 cm2 open fields 
with different isocenter doses: 0.4, 1, 1.6, 2.2 Gy. The 
electron density override on the CT for the AC was validated 
with a 2%-2mm gamma analysis on the open fields. Then a set 
of sliding window gaps (6, 10 and 14 mm) was irradiated with 
a number of MU matched to obtain 1 and 1.6 Gy at the 
isocenter plane. The mock cases from TG-119 were 
transferred to the AC CT for inverse optimization. Finally 16 
clinical HN cases were also irradiated. In the mock and HN 
cases dose was measured in a high dose-low gradient point of 
the volume. 
 
Results: The dose calculated with 3DVH for the 10x10-cm 
open fields was lower than the dose measured with the 
ionization chamber by 1.32% on average. Dose linearity was 
confirmed and the gamma passing rates were better than 95% 
for 2%/2mm criteria for all cases which confirmed our 
electron density override on the AC.  
The ratio between the dose delivered with each sweeping 
gap and a 10x10cm2 field with the same planned dose was 
calculated. The value of this relationship obtained from the 
doses reconstructed with 3DVH was 5% larger than expected, 
while the value calculated with Eclipse TPS and with the 
ionization chamber were 0.999 and 1.001, respectively. 
For the TG-119 cases we obtained that the reconstructed 
dose is 0.28% higher on average than the measured dose. The 
biggest discrepancy between reconstructed and measured 
dose was for the MultiTarget case, with a reconstructed dose 
1.42% higher than the ionization chamber measurement. The 
mock H&N case was the best of them, with an error of 0.29% 
between reconstructed and measured dose. The average on 
the reconstructed dose with 3DVH for the 16 clinical patients 
was 0.78% lower than the camera, being 0.07% the smallest 
error and 2.91% the largest one. 
 
Conclusion: Reconstructed doses over the AC phantom with 
3DVH software are in good agreement with measurements for 
open fields and also for mock cases and clinical patients. 
However, differences between calculated and measured 
doses for simple sweeping gaps are inexplicable large and 
require further investigation. 
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Purpose or Objective: The Intensity-Modulated Radiation 
Therapy (IMRT) is a widely used treatment for many cancer 
sites. Independent verification in this kind of treatment is 
recommended and some countries require it. There are many 
different ways of pre-treatment verification e.g. point dose 
measurement, 2D or 3D dose verification and various methods 
of interpreting the verification result. One of the most 
popular way is gamma evaluation [Depuydt, 2002]. The aim 
of this study was to identify the relationship between 
simulated MLC errors and gamma evaluation result. We 
compared RTdose for error-induced plans with original plan, 
both calculated in specified phantom used for verification. 
Such comparison enabled us to obtain result of gamma 
analysis influenced only by known MLC error, ceteris paribus. 
 
Material and Methods: Verification Plans for ten patients for 
each of three cancer sites (brain, prostate, head and neck) 
were prepared. For every case original and modified MLC has 
been used. Two types of MLC errors were tested: open/close 
error in which both MLC banks moved in opposite direction 
and shift error with both MLC banks moved in the same 
direction. Magnitude of these errors were 0.5, 1.0, 2.0, 3.0 
mm. The MLC errors were simulated for all control points, on 
both banks of active MLC leaves only. The dynamic leaf gap 
and other MLC physical constraints were taken into 
consideration. For each plan dose distribution was calculated 
in Eclipse (AAA v. 10.0.28) for phantom geometry and original 
gantry angles. Afterwards gamma evaluation was performed 
with the Verisoft software (PTW, v. 6.1). We investigated 
results for gamma 3mm/3%, 2mm/2%, 1mm/1% for local and 
maximum dose difference. The suppressed dose value was set 
to 10% for 3D gamma evaluation. 
 
Results: For head and neck plans MLC open/close errors, 
equal or larger than 1mm, weren’t detected only for gamma 
3mm/3% max dose and passing rate 95%. For brain and 
prostate plans 2mm open/close errors can be detected with 
gamma 3mm/3% local and 2mm/2% max dose. For all 
investigated cancer treatment sites shift errors are hard to 
detect (1 mm only with passing rate 95% gamma 1mm/1%). 
For detailed results see Figure. We assume that difference 
between treatment sites is related to the leaf open/close 





Conclusion: MLC errors may be a reason of unacceptable 
result of pre-treatment verification. Selection of gamma 
passing rate and criteria should be preceded with analysis of 
MLC error which can be detected by used verification 
method. In the case of Octavius 4D we recommend using 
3mm/3% local dose for 3D gamma evaluation in previously 
mentioned cancer sites. Other cancer sites should be also 
investigated and tested. Next step should be checking the 
